Clinical Trial Update: A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses [Phase 1]

View source ↗

Summary

A single-arm Phase 1c study evaluating XKH001 injection in patients with allergic asthma after multiple doses has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• XKH001

Snippet

Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD | Conditions: Asthma Patients | Phase 1 | Status: COMPLETED